Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sleep Number Corp Regulatory Filings 2024

May 30, 2024

33589_rf_2024-05-30_d73cab25-2b5c-492d-a19a-d7c074abc077.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

S-8 1 a2024-05x30sx8registernews.htm S-8 Document created using Wdesk Copyright 2024 Workiva Document

As filed with the Securities and Exchange Commission on May 30, 2024

Registration No. ______

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________

FORM S-8

REGISTRATION STATEMENT

UNDER THE SECURITIES ACT OF 1933

_________

Sleep Number Corporation

(Exact name of registrant as specified in its charter)

Minnesota (State or other jurisdiction of incorporation or organization) 41-1597886 (I.R.S. Employer Identification No.)
1001 Third Avenue South Minneapolis, Minnesota (Address of Principal Executive Offices) 55404 (Zip Code)

_________

Sleep Number Corporation 2020 Equity Incentive Plan

(Full title of the plan)

Samuel R. Hellfeld

Executive Vice President, Chief Legal and Risk Officer and Secretary

Sleep Number Corporation

1001 Third Avenue South

Minneapolis, Minnesota 55404

(Name and address of agent for service)

(763) 551-7000

(Telephone number, including area code, of agent for service)

Copies requested to:

Brett Hanson, Esq.

Emily Humbert, Esq.

Fox Rothschild LLP

33 South Sixth Street, Suite 3600

Minneapolis, Minnesota 55402-3601

(612) 607-7000

_________

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer Accelerated filer

Non-accelerated filer Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.

EXPLANATORY NOTE

Sleep Number Corporation (the “Registrant” or the “Company”) has filed this Registration Statement on Form S-8 (the “Registration Statement”) with the Securities and Exchange Commission (the “Commission”) pursuant to General Instruction E to Form S-8 under the Securities Act of 1933, as amended (the “Securities Act”), to register an additional 1,500,000 shares of the Company’s common stock, $0.01 par value per share (the “Common Stock”), issuable pursuant to awards granted under the Sleep Number Corporation 2020 Equity Incentive Plan, as amended (the “2020 Plan”). This share increase was approved by the Company’s Management Development and Compensation Committee on March 12, 2024, and was approved and adopted by the Company’s shareholders on May 21, 2024. The Company previously filed with the Commission a Registration Statement on Form S-8 (Reg. No. 333-238236) to register the initial 3,240,000 shares of Common Stock available for issuance under the 2020 Plan, which prior Registration Statement, with the exception of Items 3 and 8 of Part II of such prior Registration Statement, is hereby incorporated by reference.

PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3. Incorporation of Documents by Reference.

The Company hereby incorporates by reference into this Registration Statement the following documents, which have been previously filed (not furnished) with the Commission:

(a) The Company’s Annual Report on Form 10-K for the fiscal year ended December 30, 2023, including portions of the Company’s Definitive Proxy Statement on Schedule 14A filed on April 2, 2024 to the extent specifically incorporated by reference therein (File No. 0-25121);

(b) The Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 30, 2024 (File No. 0-25121);

(c) The Company’s Current Reports on Form 8-K filed on March 15, 2024 and May 21, 2024 (File Nos. 0-25121); and

(d) The description of the Common Stock contained in Exhibit 4.1 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, including any amendments or reports filed for the purpose of updating such description (File No. 0-25121).

In addition, all other documents filed (not furnished) by the Company pursuant to Section 13(a), Section 13(c), Section 14 or Section 15(d) of the Securities Exchange Act of 1934, as amended, on or after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement that indicates that all securities offered hereby have been sold or that deregisters all securities then remaining unsold shall be deemed to be incorporated in this Registration Statement by reference and to be a part of this Registration Statement from the date of filing of such documents; provided , however , that documents or information deemed to have been furnished to and not filed with the Commission in accordance with the rules of the Commission shall not be deemed incorporated by reference into this Registration Statement.

Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any

subsequently filed document which also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

Item 8. Exhibits.

The following exhibits are filed with or incorporated by reference into this Registration Statement:

Exhibit No. Description
3.1 Third Restated Articles of Incorporation of the Company, as amended (incorporated by reference to Exhibit 3.1 to the Company’s Annual Report on Form 10-K for the fiscal year ended January 1, 2000 (File No. 0-25121))
3.2 Articles of Amendment to Third Restated Articles of Incorporation of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed May 16, 2006 (File No. 0-25121))
3.3 Articles of Amendment to Third Restated Articles of Incorporation of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed May 25, 2010 (File No. 0-25121))
3.4 Articles of Amendment to Third Restated Articles of Incorporation of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed November 1, 2017 (File No. 0-25121))
3.5 Restated Bylaws of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed May 22, 2017 (File No. 0-25121))
5.1* Opinion of Fox Rothschild LLP regarding the validity of the shares of Common Stock being registered
23.1 Consent of Fox Rothschild LLP (included within the opinion filed herewith as Exhibit 5.1)
23.2* Consent of Independent Registered Public Accounting Firm
24.1* Power of Attorney (included on signature page to this Registration Statement)
99.1 Sleep Number Corporation 2020 Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed May 1 3 , 202 0 (File No. 0-25121))
99.2 Amendment No. 1 to the S leep Number Corporation 2020 Equity Incentive Plan (incorporated by reference to Exh ibit 10.1 to the Company’s Current Report on Form 8-K filed May 21 , 2024 (File No. 0-25121))
107* Filing Fee Table
  • Filed Herein.

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Minneapolis, State of Minnesota, on May 30, 2024.

SLEEP NUMBER CORPORATION

By:
Samuel R. Hellfeld
Executive Vice President, Chief Legal and Risk Officer and Secretary

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Shelly R. Ibach, Francis K. Lee and Samuel R. Hellfeld, and each of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution for him or her in any and all capacities, to sign (i) any and all amendments (including post-effective amendments) to this Registration Statement and (ii) any registration statement or post-effective amendment thereto to be filed with the U.S. Securities and Exchange Commission pursuant to Rule 462(b) under the Securities Act of 1933, as amended, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the U.S. Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

Signature Title Date
/s/ Shelly R. Ibach Chair, President and Chief Executive Officer (Principal Executive Officer) May 30, 2024
Shelly R. Ibach
/s/ Francis K. Lee Executive Vice President and Chief Financial Officer (Principal Financial Officer) May 30, 2024
Francis K. Lee
/s/ Joel J. Laing Chief Accounting Officer (Principal Accounting Officer) May 30, 2024
Joel J. Laing
/s/ Phillip M. Eyler Director May 30, 2024
Phillip M. Eyler
/s/ Stephen L. Gulis, Jr. Director May 30, 2024
Stephen L. Gulis, Jr.
/s/ Michael J. Harrison Lead Director May 30, 2024
Michael J. Harrison
/s/ Julie M. Howard Director May 30, 2024
Julie M. Howard
/s/ Deborah L. Kilpatrick Director May 30, 2024
Deborah L. Kilpatrick
/s/ Brenda J. Lauderback Director May 30, 2024
Brenda J. Lauderback
/s/ Stephen E. Macadam Director May 30, 2024
Stephen E. Macadam
/s/ Barbara R. Matas Director May 30, 2024
Barbara R. Matas
/s/ Angel L. Mendez Director May 30, 2024
Angel L. Mendez
/s/ Hilary A. Schneider Director May 30, 2024
Hilary A. Schneider